- Grazoprevir
-
- $0.00 / 1g
-
2024-12-25
- CAS:1350514-68-9
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- MK-5172
-
- $250.00 / 100g/ml
-
2021-10-29
- CAS:1350514-68-9
- Min. Order: 100g/ml
- Purity: ≥99
- Supply Ability: 20ton
- Grazoprevir
-
- $15.00 / 1KG
-
2021-07-02
- CAS:1350514-68-9
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
| Product Name: | MK5172 | | Synonyms: | 2)-ether;Grazoprevir;Grazoprevir /MK5172;(1R,2S)-N-[[[(1R,2R)-2-[5-(3-Hydroxy-6-methoxy-2-quinoxalinyl)pentyl]cyclopropyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide cyclic (1-2)-ether;(1R,18R,20R,24S,27S)-N-{(1R,2S)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-7-methoxy-24-(2-methyl-2-propanyl)-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5,7,9,11-pentaene-27-carboxamide, potassiu;Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl]cyclopropyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1→2)-ether, (1R,2S)-;MK-5172 (Grazoprevir);MK 5172 (10mM in DMSO) | | CAS: | 1350514-68-9 | | MF: | C38H50N6O9S | | MW: | 766.9 | | EINECS: | | | Product Categories: | API | | Mol File: | 1350514-68-9.mol |  |
| | MK5172 Chemical Properties |
| density | 1.38±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | ≥38.35 mg/mL in DMSO; insoluble in H2O; ≥24 mg/mL in EtOH with gentle warming and ultrasonic | | form | solid | | pka | 4.48±0.40(Predicted) | | color | White to off-white |
| | MK5172 Usage And Synthesis |
| Uses | MK 5172, also known as Grazoprevir, is a second-generation NS3/4A protease inhibitor that is often used in combination with the second-generation NS5A inhibitor, Elbasvir (E501010), for the treatment of hepatitis C virus infection. It is a COVID19-related research product. | | Definition | ChEBI: An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults. |
| | MK5172 Preparation Products And Raw materials |
|